Nilachal Refract (502294)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Small market cap of ₹105 crore may attract a strategic buyer seeking a listed shell
• Stock trades 9% below its 52-week high, suggesting some investor accumulation
• High reported ROE of 317.84%—though distorted by negative equity—signals speculative hope for a turnaround

Concerns

• Zero sales in the latest quarter with a net loss of ₹4 crore
• Negative ROCE of -77.79% indicates capital destruction
• Piotroski F-score of 3/9 reflects weak financial health
• No book value or debt data available; equity appears deeply negative

AI Analysis

Looking at Nilachal Refract, I see numbers that would make Graham turn in his grave. The latest quarter shows zero sales and a loss of ₹4 crore. There is no earnings stream, so the price-to-earnings ratio is literally zero—not because the stock is cheap, but because there is nothing to measure. The ROE of 317.84% is a mathematical mirage, likely born from a negative equity base, not from operational brilliance. ROCE is a disturbing -77.79%. A Piotroski F-score of 3/9 confirms a weak balance sheet and operations. How can one value a company with no revenue? You can't. The market cap of ₹105 crore, at ₹51.73 per share, is pure speculation. The stock has gained from its 52-week low of ₹28.88, but that doesn't create value. There is no moat, no pricing power, no brand. The company is in the electrodes and refractories space, which is cyclical, but with zero current sales, we cannot even call it a cyclical trough—it is a shell. As minority shareholders, we have no power to force a change. This is not an investment; it is a lottery ticket. Buffett would say price is what you pay, value is what you get. Here, we get zero sales, negative profit, and a negative return on capital. The company is destroying value. Even if the plant is idle, there are costs; the ₹4 crore quarterly loss is evidence. The only possible value could be in the listing status or land, but no data supports that. I would not touch it without complete books and a control perspective.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer